In situ hybridization for interleukin 2 and interleukin 2 receptor mRNA in T cells activated in the presence or absence of cyclosporin A.

PubWeight™: 1.22‹?› | Rank: Top 10%

🔗 View Article (PMC 2189101)

Published in J Exp Med on November 01, 1988

Authors

A Granelli-Piperno1

Author Affiliations

1: Rockefeller University, New York, New York 10021.

Articles citing this

Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci U S A (1989) 2.87

Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A? J Exp Med (1991) 1.48

A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation. Proc Natl Acad Sci U S A (1996) 1.42

During HIV-1 infection most blood dendritic cells are not productively infected and can induce allogeneic CD4+ T cells clonal expansion. Clin Exp Immunol (1992) 1.36

The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter. J Exp Med (1990) 1.18

IL-2 mRNA expression in Tac-positive malignant lymphomas. Am J Pathol (1990) 1.17

Lymphokine gene expression in vivo is inhibited by cyclosporin A. J Exp Med (1990) 1.14

Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A. Br J Ophthalmol (1997) 1.08

Expression of cytolytic mediators by synovial fluid lymphocytes in rheumatoid arthritis. Am J Pathol (1992) 0.91

Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis? Br J Ophthalmol (1995) 0.86

Constitutive IL-2 expression in HTLV-I-infected leukaemic T cell lines. Clin Exp Immunol (1991) 0.81

Early IL-2/sIL-2R surge following surgery leads to temporary immune refractoriness. Clin Exp Immunol (1993) 0.80

Immunosuppression follows systemic T lymphocyte activation in the burn patient. Clin Exp Immunol (1991) 0.80

Interleukin-22 and Cyclosporine in Aggressive Cutaneous Squamous Cell Carcinoma. Dermatol Clin (2017) 0.75